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Abstract
Two eps8 isoforms, p97eps8 and p68eps8, were previously identified as substrates for receptor tyrosine kinases. Analysis of
eps8 phosphotyrosine content in v-Src transformed cells (IV5) revealed that both isoforms were highly tyrosyl
phosphorylated and their readiness to be phosphorylated by Src in vitro further indicated that they were putative Src
substrates as well. Indeed, the enhancement of tyrosyl phosphorylation of p97eps8 detected in cells coexpressing both p97eps8
and active Src relative to that in cells expressing p97eps8 alone supported our hypothesis. The existence of common
phosphotryptic peptides between in vitro 32P-labeled p97eps8 and p68eps8 indicated that these two proteins shared the same
Src-mediated sites. Further in vitro binding assays demonstrated that p68eps8 was the major eps8 isoforms that could be
precipitated by bacterial fusion protein containing Src SH3. Interestingly, both p68eps8 and p97eps8 were preferentially
expressed in v-Src transformed cells and the presence of p68eps8 appeared to depend on Src. Since p97eps8 has been implicated
in mitogenesis and tumorigenesis, its readiness to be phosphorylated and induced by v-Src might attribute to v-Src-mediated
transformation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
EGF receptor (EGFR), a 170-kDa receptor tyro-
sine kinase, dimerizes and becomes autophosphory-
lated upon EGF stimulation. Through the binding
between pTyr and SH2, a number of SH2-containing
molecules, such as PLCQ, p85 subunit of PI-3 kinase,
Grb2 and Shc become associated with EGFR [1].
Some of these proteins are further phosphorylated
by EGFR, enzymatically activated (e.g. PLCQ [2])
and sometimes become the binding site(s) for other
SH2 containing protein(s) (e.g. the Grb2 binding site
on Shc [3]), thereby leading to the propagation of the
EGF-induced signaling. On the other hand, proteins
that devoid of SH2 domain, but still involved in
EGF-induced signaling, have also been identi¢ed. A
prominent example is eps8 [4].
Eps8 was initially identi¢ed as a substrate for the
EGFR whose tyrosyl phosphorylation was increased
in response to EGF [4]. Further studies indicated
that eps8 could also be phosphorylated in response
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to stimulation by various ligands including platelet-
derived growth factor and acidic ¢broblast growth
factor [4]. There is a direct interaction between
EGFR and eps8 that involves the juxtamembrane
region of EGFR and the basic region of eps8, respec-
tively [5]. Direct cloning of the cDNA of the EGFR
substrates led to the isolation of p97eps8 cDNA. And
its sequence analysis revealed the following domains
which might contribute to its cellular functions: an
SH3 domain, a putative nuclear targeting sequence, a
PH domain, several potential SH3-binding sites, and
a degenerated SH2 at the amino terminus. The eps8
SH3 domain has been shown to interact with Shc [6],
Shb [7], RN-tre [8], and e3B1 [9]. And interestingly,
based on its deduced tertiary structure, eps8 SH3
domain has also been implicated in the formation
of eps8 dimer [10]. Meanwhile, proteins associated
with other domains of eps8 have not been identi¢ed.
p97eps8 has been implicated in EGF-induced mito-
genesis and tumorigenesis since its overexpression
in cells can enhance the EGF-dependent mitogenic
e¡ect and focus-forming ability [4,6]. Consistent
with this notion was its constitutive tyrosyl phos-
phorylation detected in several tumor cell lines [6].
Interestingly, in some cell lines, antibodies against
p97eps8 could also recognize a 68-kDa protein
(p68eps8), which has been speculated as a proteolytic
or an alternatively spliced product of p97eps8 [4]. The
exact nature of the coding sequences and the func-
tions of p68eps8 remain to be established. In addition
to mitogenesis and tumorigenesis, the reduced ex-
pression of both eps8 isoforms in myogenic cells sug-
gest that eps8 might also be involved in terminal
di¡erentiation [11].
Rous sarcoma virus (RSV)-encoded v-Src is the
¢rst identi¢ed oncoprotein with tyrosine kinase activ-
ity. Its tyrosine-speci¢c protein kinase activity is pro-
ven to be essential for cellular transformation. In
v-Src transformed cells, more than 20 proteins have
their pTyr contents increased and are viewed as pu-
tative v-Src substrates [12^14]. Interestingly, some of
them (i.e. cortactin, Shc, and GAP) turn out to be
the substrates for EGFR as well [15^20]. It was
speculated that constitutive phosphorylation of these
common substrates in cells expressing v-Src might
contribute to cellular transformation. In this study,
we present evidence, as shown below, describing that
eps8 isoforms were Src substrates as well.
First of all, both p97eps8 and p68eps8 were highly
tyrosyl phosphorylated in v-Src transformed cells. In
an immunocomplex kinase reaction, v-Src could di-
rectly phosphorylate both eps8 isoforms in vitro. In-
terestingly, the bacterial GST fusion protein contain-
ing the N-terminus of p97eps8 not only could be
directly phosphorylated by baculovirus expressed
Src, but also shared a common phosphotryptic pep-
tide derived from v-Src phosphorylated p97eps8. Be-
sides, bacterial fusion protein containing Src SH3
could preferentially precipitate p68eps8 in the in vitro
binding reactions. Finally, enhanced tyrosyl phos-
phorylation of p97eps8 was detected in cells coex-
pressing both p97eps8 and active Src, but not in cells
expressing p97eps8 alone. Interestingly, in addition to
tyrosyl phosphorylation, the protein levels of both
eps8 isoforms were much higher in v-Src transformed
cells than the normal control cells. Since p97eps8 has
been implicated in mitogenesis and tumorigenesis, its
readiness to be phosphorylated and induced by v-Src
may contribute to the transformation caused by v-
Src.
2. Materials and methods
2.1. Cloning of the murine p97eps8 full-length open
reading frame (ORF) and the generation of its
expression plasmid
According to the published sequences of p97eps8
cDNA [4], two 18-mers P1 and P2 (nt 606^623 and
nt 908^923, respectively; Fig. 1) were utilized as pri-
mers for polymerase chain reaction (PCR) of the
cDNA derived from mouse 11-day embryo (Clon-
tech). A PCR product with 318 nucleotides was gen-
erated and utilized as a probe to screen the mouse
11-day embryo cDNA library. Two eps8-related
Vgt11 clones, 2Aa and 12Aa (Fig. 1), were isolated
from V106 plaques and shown to be completely
overlapped. Both clones have been sequenced with
Sanger-dideoxy method and mapped with restriction
enzyme digestion. The 2Aa clone contains almost all
the ORF of p97eps8 except the sequences correspond-
ing to the C-terminal end of eps8 (amino acid (aa)
668^821). In order to make up the missing protein-
encoding region of p97eps8, another set of oligonu-
cleotides, P3 and EcoRI-tagged P4, which corre-
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spond to nt 32072 to 32091 and nt 32705 to
32720, respectively (Fig. 1), were utilized as primers
for the PCR of the same mouse embryonic cDNA.
The resulting PCR product was digested with PvuII/
EcoRI and this fragment was inserted into the
EcoRI-digested pBluescript vector along with the
EcoRI/PvuII-digested 2Aa to generate the full length
of p97eps8-containing pBS-eps8 plasmid (Fig. 1). The
bacterial expression plasmid (pGEX-c-eps8; Fig. 1)
was constructed by cloning the BglII/EcoRI digested
C-terminal eps8 fragment (which encodes aa 3355 to
3668) into the BamHI/EcoRI sites of a GST expres-
sion vector pGEX-1 [21]. The construction of eu-
karyotic p97eps8 expression plasmid (i.e. RCAS-
eps8, Fig. 1) is brie£y described as the following.
The eps8 cDNA (i.e. the NaeI/HindIII digested frag-
ment derived from the plasmid pBS-eps8) was ¢rst
subcloned into the SmaI and HindIII sites of the
Cla12Nco vector and then recloned into the ClaI
site of an avian retroviral expression vector, RCAS
A (BH) as described previously [22]. The pGEX-N/
RV which encodes the N-terminal p97eps8 (i.e. GST-
N/RV, aa 1^179) is constructed as the following: the
NaeI/EcoRV fragment derived from PBS-eps8 was
¢rst cloned into the SmaI site of pGEM-7Zf(+)
and then the BamHI/EcoRI fragment derived from
this new construct was ligated with the BamHI/
EcoRI-digested pGEX-2T.
2.2. Cells and cellular lysate preparation
The clonal C3H10T1/2 murine ¢broblast cell lines
(Neo and IV5) were generous gifts provided by Dr.
Sarah J. Parsons and their derivation and mainte-
nance were previously described [23,24]. Primary
chicken embryo (CE) cells were maintained and
transfected with retroviral vector as previously de-
scribed [25,26]. Replication-competent RCAS A
(BH) and RCAS B (BH) retroviral vectors were
used for the expression of p97eps8 and active Src
(Src 518amb, a Src mutant with an amber mutation
at amino acid residue 518 [27]), respectively. For
generation of CE cells overexpressing both p97eps8
and active Src, cultured medium containing high-titer
viral stock was collected from Src transfected cells
and incubated with p97eps8 overexpressors. After
few passages, the expression of Src and p97eps8 in
these cells was con¢rmed. Cells grown to near con-
£uency were lysed in modi¢ed RIPA bu¡er as de-
scribed before [26] and protein concentration was
determined by protein assay kit (Bio-Rad).
2.3. Antibody generation, immunoprecipitation and
immunoblotting of eps8
Rabbit antiserum against carboxyl portion of
p97eps8 (C-eps8) was raised against a GST-eps8 bac-
terially expressed fusion protein containing murine
p97eps8 residues 355^668. Near 1 mg of cellular ly-
sates were immunoprecipitated with either C-eps8
antibody generated in our laboratory or the eps8
antibody provided by Dr. Pier Paolo Di Fiore [4].
The eps8 immunocomplexes were resolved on 8%
Fig. 1. Schematic illustration of various eps8 constructs. The
full-length eps8 cDNA is indicated on the top and its open
reading frame is marked as a closed box. Two Vgt11 clones,
12 Aa and 2 Aa, obtained by screening a mouse 11-day embryo
cDN library are demonstrated. The full-length open reading
frame of p97eps8 was constructed in Bluescript vector (pBS-
eps8) and RCAS (A) vector (RCAS-eps8) as described in Sec-
tion 2. Also indicated is pGEX-c-eps8 that encodes a bacterial
GST fusion protein containing C-terminal eps8 (aa 355^668).
The restriction enzyme cutting sites are indicated above each
drawing (B, BamHI; N, NaeI; Bg, BglII; P, PvuII; R, EcoRI).
P1, P2, P3 and P4 represented the primers utilized in the PCR
reactions described in Section 2.
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SDS-polyacrylamide gels, transferred to nitrocellu-
lose membranes and probed with rabbit polyvalent
serum against phosphotyrosine or eps8. Binding of
rabbit antiserum to membrane was detected with
protein A labeled with 125I or conjugated with horse-
radish peroxidase (ECL; Amersham).
2.4. In vitro kinase reactions
p97eps8 was immunoprecipitated from C3H10T1/2
cells while v-Src was immunoprecipitated from IV5
cells. These two immunoprecipitates were either in-
cubated alone or together in the kinase bu¡er (5 mM
MgCl2, 5 mM MnCl2, 20 mM PIPES (pH 7.5), 50
WM ATP) containing 10 WCi [Q-32P]ATP (Dupont/
NEN) for 15 min at room temperature. Incubations
were terminated by addition of sample bu¡er. After
5-min boiling, the labeled products were resolved by
SDS/PAGE and visualized by autoradiography. The
same experiment was also carried out by incubation
of both the bacterial expressed GST-N/RV fusion
protein and the puri¢ed baculovirus-expressed hu-
man c-Src (UBI, Lake placid, New York).
2.5. Phosphoamino acid analysis
The 32P-labeled p97eps8 was excised from the gel,
eluted out, precipitated with trichloroacetic acid,
washed with ethanol and hydrolyzed in 100 Wl of
6.0 M HCl at 110‡C for 30 min [28]. Hydrolyzed
32P-labeled p97eps8 (V500 cpm) was mixed with
0.3 Wg of each authentic phosphoserine, phospho-
threonine and phosphotyrosine, and resolved by 2D
thin layer electrophoresis [28]. Ninhydrin staining of
authentic phosphoamino acids was used as a refer-
ence for autoradiographic identi¢cation of labeled
phosphoamino acids.
2.6. Two-dimensional phosphotryptic
peptide mapping
The 32P-incorporated p97eps8 and p68eps8 were ex-
tracted from an SDS-polyacrylamide as described
above. Each protein was then digested with trypsin
and analyzed by 2D-thin layer chromatography as
described previously [26]. Brie£y, the tryptic peptides
of each digestion (V1000 cpm) were resolved on
Fig. 2. Both p97eps8 and p68eps8 are highly tyrosyl phosphorylated in v-Src transformed cells. Equal amounts (1 mg) of cell lysates pre-
pared from Neo (odd numbers) or IV5 (even numbers) were immunoprecipitated with rabbit polyvalent serum against eps8 either gen-
erously provided by Dr. Di Fiore (eps8 Ab) or prepared in our laboratory (C-eps8). Immunoprecipitation carried out with non-speci¢c
rabbit serum (PI) was used for negative control. The immunocomplexes were equally split into two parts ; one-half was immunoblotted
with antibody against eps8 (DiFiore’s Ab) (A), and the other half was analyzed by pTyr Western immunoblotting (B). IP, immuno-
precipitation.
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cellulose thin-layer plates by electrophoresis in the
¢rst dimension (15 min at 1500 V in pH 1.9 bu¡er
[28]) and ascending chromatography in the second
dimension (in phospho chromatography bu¡er
[28]).
2.7. In vitro solution binding assay
Bacterially expressed GST fusion proteins contain-
ing Src SH3 and SH2 alone or both were immobi-
lized on glutathione-Sepharose 4B beads as described
previously [25]. Then beads containing various
amounts of each fusion protein were incubated
with 400 Wg of cellular lysates prepared from IV5
cells. After 12 h of gentle mixing at 4‡C, complexes
were gently washed with modi¢ed RIPA bu¡er once
and Tris-saline bu¡er (150 mM NaCl, 50 mM Tris-
HCl, pH 7.4) three times and Western blotted with
monoclonal anti-eps8 antibody purchased from
Transduction Laboratories (Kentucky, USA) and de-
tected by ECL.
3. Results
3.1. Eps8 was highly tyrosyl phosphorylated in v-Src
transformed cells
To test the possibility that eps8 may be a substrate
for Src, total lysates prepared from normal (Neo) or
v-Src transformed cells (IV5) were immunoprecipi-
tated with eps8 polyclonal antibodies that either pro-
vided by Dr. Di Fiore (eps8, Fig. 2) or generated in
our laboratory (C-eps8). The anti-eps8 immunopre-
cipitates were then examined for protein tyrosyl
phosphorylation by anti-phosphotyrosine (anti-
pTyr) immunoblotting. As demonstrated in Fig. 2B,
while both p97eps8 and p68eps8 isoforms were highly
tyrosyl phosphorylated in IV5 cells, little tyrosyl
phosphorylation of these proteins was observed in
normal cells. Furthermore, anti-eps8 immunoblotting
revealed that p97eps8 was the major form of eps8 ex-
pressed in normal cells and about twice as much was
expressed in v-Src transformed cells (Fig. 2A, lanes
Fig. 3. v-Src was capable of phosphorylating p97eps8 in vitro. Eps8 and Src immunocomplexes were derived from Neo and IV5, re-
spectively. These two immunocomplexes were either incubated alone or mixed together, and subjected to in vitro kinase reactions. The
32P-labeled proteins were analyzed by SDS/PAGE and detected by autoradiography (20 min exposure) (A). The position of p97eps8 is
indicated on the left. A potential 32P-labeled p68eps8 in the Src immunocomplex is marked with an asterisk. The 32P-labeled p97eps8
was excised and extracted for phosphoamino acid analysis by 2D electrophoresis (the ¢rst dimension was in pH 1.9 bu¡er, and the
second dimension was in pH 3.5 bu¡er) (B). pS, phosphoserine; pT, phosphothreonine; pY, phosphotyrosine.
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2 and 4). And surprisingly, the expression of p68eps8
was dependent on the presence of v-Src (Fig. 2A).
None of eps8 was detected in the immunocomplexes
precipitated by preimmunized antibody, although a
few non-speci¢c tyrosyl phosphorylated proteins
were recognized (Fig. 2, lanes 5 and 6).
3.2. v-Src can directly phosphorylate p97eps8 in vitro
The increased phosphorylation of eps8 isoforms in
v-Src transformed cells can be attributed to either
direct or indirect phosphorylation mediated by v-
Src. To di¡erentiate these two possibilities, eps8 im-
munoprecipitates prepared from normal cells (Neo)
were either incubated alone or with IV5-derived v-
Src immunoprecipitates in the presence of [Q-32P]ATP
and subjected to in vitro kinase assays. As shown in
Fig. 3A, in the absence of v-Src, eps8 immunopreci-
pitates prepared from normal cells did not exhibit
any obvious 32P-labeled proteins. By contrast, v-Src
and its associated proteins became 32P-labeled in v-
Src immunoprecipitates. When eps8 and v-Src immu-
nocomplexes were incubated together, p97eps8 be-
came 32P-labeled. To exclude the possibility that
p97eps8 is phosphorylated by the Src-associated ser-
ine/threonine kinase and not by Src itself, phospho-
amino acid analysis of in vitro 32P-labeled p97eps8 was
carried out. As shown in Fig. 3B, only 32P-labeled
phosphotyrosine was detected. This result suggested
that v-Src was capable of directly phosphorylating
p97eps8. A similar result was detected when Src im-
munocomplex was substituted by baculovirus ex-
pressed Src to carry out the in vitro kinase reactions
(data not shown). Further evidence came from the in
vitro phosphorylation of the bacterial GST fusion
protein containing the N-terminus of p97eps8 (GST-
N/RV; with amino acids 1^179) by baculovirus ex-
pressed Src (Fig. 4A). Analysis of the phosphotryptic
map of the 32P-incorporated GST-N/RV mediated by
baculovirus expressed Src revealed the co-migration
of the major phosphotryptic peptide (Fig. 4B, upper
panel) with the one generated from v-Src phospho-
rylated p97eps8 (Fig. 4B, middle panel; spot d). We
concluded that p97eps8 was indeed directly phos-
phorylated by Src, at least, on a Tyr residue located
at its N-terminus.
3.3. The existence of p68eps8 in v-Src
immunocomplexes
Carefully examined the 32P-labeled proteins in v-
Src immunoprecipitates, a protein with the molecular
weight close to 68 kDa was detected (Fig. 3A, band
marked with asterisk). This prompted us to speculate
the possibility that this protein might be p68eps8. To
Fig. 4. Baculovirus-expressed Src is capable of phosphorylating
the bacterial GST fusion protein containing the N-terminus of
p97eps8 in vitro. In vitro kinase reactions were carried out with
the GST fusion protein containing the N-terminus of p97eps8
(GST-N/RV) in the presence or absence of baculovirus-ex-
pressed Src (Bac Src). The 32P-labeled proteins were analyzed
by SDS/PAGE and detected by autoradiography (10 min expo-
sure) (A). The tryptic phosphopeptide map of baculovirus Src
phosphorylated GST-N/RV fusion protein was prepared (1000
cpm) (B, upper panel). To con¢rm the identity of the major
phosphopeptide, the recovered arrow-pointed one (120 cpm)
was mixed with the tryptic peptides derived from v-Src phos-
phorylated p97eps8 (500 cpm) (B, lower panel). For comparison,
the tryptic phosphopeptide map of v-Src phosphorylated p97eps8
is also demonstrated (1000 cpm) (B, middle panel). Unambigu-
ously, the arrow-pointed spot is identical to spot d as desig-
nated in Fig. 5. The asterisks represent the position of origin in
all panels.
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prove this speculation, the in vitro 32P-labeled p97eps8
and the asterisk-marked protein were eluted from the
gel, subjected to trypsin digestion and phosphotryp-
tic peptide map analysis. As shown in Fig. 5, the
common phosphotryptic peptides shared by these
two proteins (spots a, b, c, e) indicating that the
asterisk-marked protein should correspond to
p68eps8 since they shared the common phosphory-
lated sites mediated by v-Src. Also, the detection of
p68eps8 in v-Src immunocomplexes suggested the as-
sociation between p68eps8 and v-Src in vivo (see Sec-
tion 4).
3.4. v-Src can preferentially associate with p68eps8 in
vitro through its SH3 domain
Though no available co-immunoprecipitation data
supporting the association between eps8 isoforms
and v-Src, the detection of p68eps8 in v-Src immuno-
precipitates in the in vitro kinase reaction did suggest
the interaction between these two proteins. Since
there were putative SH3-binding motifs in p97eps8,
we wondered whether it was possible that through
these sites eps8 isoforms were capable of associating
with Src SH3 domain. To address this question,
whole cell lysates prepared from v-Src transformed
cells were incubated with GST-SrcSH2, GST-
SrcSH3, or GST-SrcSH3SH2. The proteins bound
to these bacterial fusion proteins were then resolved
with SDS/PAGE and immunoblotted with anti-eps8
antibody. As demonstrated in Fig. 6, though tiny
amounts of p97eps8 were associated with SrcSH3,
p68eps8 was the major eps8 isoforms that could com-
plex with SrcSH3. By contrast, no association was
detected between eps8 isoforms and SrcSH2 and no
synergistic e¡ect was observed in SrcSH3SH2. This
implicated that SH3 was the domain within v-Src
that could mediate the interaction between eps8 iso-
forms and Src.
Fig. 5. Comparative tryptic phosphopeptide maps for in vitro Src-phosphorylated p97eps8 and p68eps8. The 32P-incorporated p97eps8
(A) and p68eps8 (B) harvested from the in vitro kinase reaction (Fig. 3) were digested with trypsin. The resulting phosphopeptides
(V1000 cpm) were separated into two dimensions by electrophoresis (pH 1.9) and chromatography on thin layer plates and detected
by autoradiography as described in Section 2. (C) Tryptic map of the mixture of peptides in A and B. (D) Schematic drawing of the
eps8-derived phosphotryptic peptides mediated by Src. The asterisk represents the position of origin in each panel.
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3.5. Active Src can mediate the phosphorylation of
p97eps8 in vivo
Once p97eps8 was con¢rmed to be a direct substrate
for v-Src in vitro, the next question turned out to be
whether an active Src was capable of mediating
p97eps8 phosphorylation in vivo. To address this
question, a retrovirus expression system was utilized
to express p97eps8 alone or p97eps8 and active Src (i.e.
Src518am) both in chicken embryo (CE) cells. As
shown in Fig. 7A, multiple tyrosyl phosphorylated
proteins were detected in cells overexpressing both
p97eps8 and active Src as compared to that in paren-
tal CE cells and cells overexpressing p97eps8 alone
(Fig. 7A, lanes 1^3). Further analysis of the eps8
levels and their pTyr contents revealed that only in
the presence of active Src can p97eps8 become highly
tyrosyl phosphorylated (Fig. 7A,B, lanes 5 and 6).
This result suggests that indeed active Src can medi-
ate p97eps8 phosphorylation in vivo. The failure of
detection of chicken endogenous p97eps8 might be
due to the antibodies used in this study cannot rec-
ognize the chicken counterpart and/or there was no
p97eps8 expression in chicken cells.
4. Discussion
In this study, based on the following observation,
we demonstrated that both eps8 isoforms were Src
substrates. These were: (1) v-Src immunocomplexes
and baculovirus-expressed c-Src could directly phos-
phorylate both eps8 isoforms in vitro; (2) the detec-
tion of p68eps8 in v-Src immunoprecipitates; (3) asso-
ciation with p68eps8 with SrcSH3; and (4) expression
of v-Src or active Src could lead to the enhancement
of p97eps8 tyrosyl phosphorylation in vivo. Since
EGFR and Src are two common active tyrosine ki-
nases involved in neoplastic growth and both are
capable of phosphorylating the two eps8 isoforms,
the constitutive tyrosyl phosphorylation of p97eps8
detected in several tumor cell lines may be mediated
by these kinases or their relatives. Comparing to the
eps8 immunoprecipitates alone, the failure of detect-
ing the enhancement of 32P-labeled p68eps8 in the
presence of Src was likely due to the low abundance
of p68eps8 in Neo lysates that was utilized for the
preparation of eps8 immunocomplexes (Fig. 3A,
left and middle lanes). A 32P-labeled protein with
the molecular weight of 68 kDa, however, was de-
tected in the Src immunocomplexes prepared from
IV5 cell lysates (Fig. 3A, middle lane; protein
marked with an asterisk). Further 2D phosphotryptic
peptide analysis of the in vitro 32P-labeled p97eps8
and the putative p68eps8 revealed that both shared
most of the tryptic peptides (Fig. 5) although Src-
mediated sites were preferentially located on d for
p97eps8 and c, e for p68eps8 respectively. Since d was
also detected in the tryptic map derived from GST
fusion protein containing the ¢rst 179 N-terminal
amino acids of p97eps8 phosphorylated by baculovi-
rus expressed Src (Fig. 4B), thus, it implicated that
most likely p68eps8 did not contain this region or this
Fig. 6. Solution binding of eps8 to Src SH3 domain in v-Src
transformed cells. Lysates (400 Wg) from IV5 cells were incu-
bated with GST-SrcSH3 2 Wg (lane 2); 4 Wg (lane 3); GST-
SrcSH3SH2 8 Wg (lane 5); GST-SrcSH2 6 Wg (lane 6) as de-
scribed in Section 2. The precipitated proteins in each group
along with IV5 lysates (15 Wg) (lane 1) and GST-SrcSH3 4 Wg
alone (lane 4) were resolved on SDS/PAGE and analyzed by
Western immunoblotting with monoclonal eps8 antibody pur-
chased from Transduction Laboratories. The positions of vari-
ous GST fusion proteins are marked with asterisks.
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region was preferentially phosphorylated in p97eps8.
These results not only suggested that Src could phos-
phorylate these two eps8 isoforms at the same tyro-
sine residues, but also con¢rmed that these two eps8
isoforms were indeed derived from the same gene
product.
Previously, Gallo et al. described the enhancement
of p97eps8 tyrosyl phosphorylation in response to Src
activation [11] and the similar result was observed in
this study. However, one cannot exclude the possi-
bility that other Src-activated tyrosine kinases ac-
tually do this job. To clarify this point, we demon-
strated that both Src immunocomplexes and puri¢ed
baculovirus-expressed Src could indeed mediate
p97eps8 phosphorylation and a tyrosine residue lo-
cated at p97eps8 N-terminus turned out to be one of
the sites mediated by Src. Based on the conclusion
derived from Songyang et al. E/D-E/D-I/V/L-Y-G/E-
E-F-D/E was the speci¢c sequence that can be phos-
phorylated by Src [29]. However, no such sequence
was present at the N-terminus of p97eps8. Neverthe-
less, sequences composing Tyr-12 (G-Y-G), Tyr-15
(V-Y-P), Tyr-22 (G-Y-G), Tyr-45 (L-Y-E) showed
limited homology with the Src phosphorylation con-
sensus sequences and among them, Tyr-45 was the
most likely candidate. Further experiments are now
in progress to identify and characterize the Src-medi-
ated sites on p97eps8.
The detection of p68eps8 in v-Src immunocom-
plexes in the in vitro kinase reaction suggested the
association of p68eps8 and v-Src in vivo. Indeed, we
demonstrated that it was the Src SH3, not SH2
which mediated this interaction (Fig. 6) and the stoi-
chiometry was estimated to be 2^3% in our experi-
ments. This low stoichiometry could be interpreted
by the weak interaction between Src SH3 and the
proline-rich sequence. Thus, we had di⁄culty in de-
tecting both eps8 isoforms in the v-Src immunocom-
plexes in the traditional co-immunoprecipitation ex-
periments. Since association with the Src SH3 or
SH2 domain usually leads to tyrosyl phosphorylation
of various Src substrates [30], therefore, it is likely
that the same mechanism results in the tyrosyl phos-
phorylation of eps8. In supporting this hypothesis,
we observed that baculovirus expressed Src can me-
diate the phosphorylation of GST-N/R. However,
the phosphorylation stoichiometry was low (0.4 mol
Pi/mol; data not shown), and this result might be
due to the absence of Pro-rich sequences in the
N-terminal 179 amino acids of p97eps8. Further ex-
Fig. 7. Active Src can mediate p97eps8 tyrosyl phosphorylation in vivo. Cellular lysates (lanes 1^3) and p97eps8 immunocomplexes
(lanes 4^6) were resolved in an SDS/PAGE and analyzed by Western immunoblotting with either pTyr antibody (A) or C-eps8 anti-
body (B). The position of p97eps8 and IgG are indicated on the right. Lanes 1 and 4, CE cells ; lanes 2 and 5, CE cells expressing
p97eps8 ; lanes 3 and 6, CE cells expressing both active Src (Src 518amb) and p97eps8.
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periments demonstrating reduction or abolishment of
eps8 tyrosyl phosphorylation in cells expressing SH3-
defective Src are needed to support this hypothesis.
Meanwhile, analysis of amino acid sequences of eps8
revealed several proline-rich regions potential for Src
SH3 binding. However, none of them resembled the
known optimal Src-SH3 binding motif, such as
RPLPXXP [31,32]. Synthesis of these proline-rich
peptides and determination of their Src SH3 binding
a⁄nity can pinpoint the one responsible for Src SH3
binding.
In addition to tyrosyl phosphorylation, the ele-
vated expression of both eps8 isoforms was also ob-
served in v-Src transformed cells (Fig. 2A). Further
analysis of the Northern blots prepared from normal
and v-Src transformed cells revealed that the abun-
dance of two major eps8 transcripts paralleled with
that of their encoded proteins (data not shown).
Thus, the di¡erential expression of eps8 isoforms in
normal and v-Src transformed cells might be in part
due to transcriptional regulation. Since overexpres-
sion of p97eps8 has been implicated in the enhance-
ment of EGF-induced mitogenesis and tumori-
genesis, we speculated that Src-mediated eps8
overexpression might minimize the requirement of
growth factors (or serum) needed for cellular growth
and contributed to the oncogenesis induced by Src.
This hypothesis is now under investigation.
The signi¢cance of tyrosyl phosphorylation and/or
expression of p97eps8 in mitogenesis and tumorigene-
sis has been implicated by Matoskova et al. [6].
Based on our ¢ndings in this study, it was likely
that Src-mediated tyrosyl phosphorylation and pro-
tein expression of eps8, especially the p68eps8, may be
involved in v-Src-induced transformation. Further
studies of the levels of eps8 tyrosyl phosphorylation
and protein expression in cell lines expressing various
v-Src mutants that are transformation defective will
be needed to support this speculation.
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